Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score

Liangshan Wang1, Feng Yang1, Xiaomeng Wang1

  • 1Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

Insights

A new REMEMBER score predicts in-hospital mortality for coronary artery bypass grafting patients on venoarterial extracorporeal membrane oxygenation. This score aids clinicians in managing cardiogenic shock post-CABG.

Area of Science:

  • Cardiovascular Surgery
  • Critical Care Medicine
  • Medical Informatics

Background:

  • No established prediction scoring systems exist for coronary artery bypass grafting (CABG) patients requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO).
  • Developing such a score is crucial for managing cardiogenic shock in this high-risk population.

Purpose of the Study:

  • To develop and validate a predictive score for in-hospital mortality in patients undergoing VA-ECMO after isolated CABG.
  • To identify key pre-ECMO parameters associated with mortality.

Main Methods:

  • Retrospective cohort study of 166 CABG patients supported with VA-ECMO.
  • Multivariable logistic regression analysis to identify predictors of mortality.
  • Development of the REMEMBER score based on identified parameters.

Main Results:

  • The REMEMBER score was developed using six pre-ECMO parameters: age, left main coronary artery disease, inotropic score, CK-MB, serum creatinine, and platelet count.
  • Four risk classes were defined, showing increasing mortality rates from 13% (Class I) to 94% (Class IV).
  • The REMEMBER score demonstrated superior predictive accuracy (AUC 0.85) compared to existing scores (SOFA, SAVE, EuroSCORE, ENCOURAGE).

Conclusions:

  • The REMEMBER score can assist clinicians in predicting in-hospital mortality for VA-ECMO patients post-CABG with refractory cardiogenic shock.
  • External validation through prospective studies is recommended to confirm the score's utility.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686
Introduction to z Scores01:06

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.2K